Hep Email Update
Aging and Hepatitis C
Compared with younger people with hepatitis C, older adults are at a disadvantage.
Bulevirtide Continues to Show Promise for People With Hepatitis D
The new drug reduced HDV viral load and lowered liver enzyme levels in people with hepatitis B and D.
Ex-Moderna Exec Named President of the Baruch S. Blumberg Institute
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
Advertisement
West Virginia Increases Access to Hepatitis C Treatment for State Medicaid Beneficiaries
The state recently lifted its prescriber restrictions and sobriety restrictions, joining a growing number of states to lift barriers.
COVID-19 Was Third Leading Cause of Death in the United States in Both 2020 and 2021
The pandemic also disrupted medical care and had an indirect effect on other causes of death.
The Hep Magazine Archives

To read past issues of Hep, click the link!

Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2022 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.